Spectral Medical Inc. EDT.TO
Set alert
As of Nov 2, 3:59 PM ET
- YTD
- -28.47%
- 1 year
- -30.41%
- Open
- 1.03
- Prev close
- 1.03
- Mkt cap
- 302.36M
- Vol
- 130.24K
- Avg vol
- 57.07K
- EPS
- -0.12
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.00
- High
- 1.06
- Forward P/E
- -9.70
- Beta
- 1.00
- Short ratio
- 1.04
- Inst. own
- 12.95%
- Dividend
- 0.00
- Ex-div date
- Dec 18, 2011
- 50-d avg
- 0.5511
- 200-d avg
- 0.533575
- 1y target
- 2.00
2Y chart
Signals (74)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 27, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 23, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 17, 2026 | 3 months ago |
Newest 20 of 74.
Key statistics
- Market cap
- 137.17M
- Enterprise value
- 171.45M
- Trailing P/E
- 0.00
- Forward P/E
- -9.70
- PEG ratio
- 0.00
- Price / sales
- 72.15
- Price / book
- 0.00
- EPS (TTM)
- -0.10
- Beta
- 1.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.90M
- Revenue growth
- 53.90%
- Free cash flow
- 5.16M
- Total cash
- 7.54M
- Total debt
- 13.05M
- Return on equity
- 0.00%
- Shares outstanding
- 282.82M
- Short % of float
- 0.00%
- 50-day average
- 0.5511
- 200-day average
- 0.533575
Analyst view
Consensus: none
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
About Spectral Medical Inc.
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Canada
- Website
- spectraldx.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on EDT.TO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Benedetti & Gucer, Inc. | 0.01% | 22,200 | 10.77K | Mar 30, 2023 |